The unique shape of the DTRAX Graft provides indirect decompression and fusion and can be used in conjunction with injectable bone graft material and/or supplemental stabilization.
It is currently being sold into the U.S. market.
As DTRAX Graft is regulated as a HCT/P (Human Cell and Tissue Product), it does not carry a specific indication from the FDA.
Request Product Information